Osterweis Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Osterweis Capital Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-50,000	Closed	-$19K	–	112
2017 Q2	$19K	Hold	50,000	–	–	﹤0.01%	95
2017 Q1	$23K	Hold	50,000	–	–	﹤0.01%	91
2016 Q4	$19K	Hold	50,000	–	–	﹤0.01%	86
2016 Q3	$14K	Hold	50,000	–	–	﹤0.01%	87
2016 Q2	$12K	Hold	50,000	–	–	﹤0.01%	84
2016 Q1	$6K	Hold	50,000	–	–	﹤0.01%	82
2015 Q4	$6K	Hold	50,000	–	–	﹤0.01%	54
2015 Q3	$10K	Hold	50,000	–	–	﹤0.01%	60
2015 Q2	$35K	Hold	50,000	–	–	﹤0.01%	66
2015 Q1	$34K	Sell	50,000 -88,300	-64%	-$61.7K	﹤0.01%	66
2014 Q4	$110K	Buy	138,300 +50,000	+57%	+$34.2K	﹤0.01%	67
2014 Q3	$41K	Hold	88,300	–	–	﹤0.01%	69
2014 Q2	$44K	Sell	88,300 -84,000	-49%	-$40.6K	﹤0.01%	68
2014 Q1	$53K	Buy	172,300 +128,150	+290%	+$47.6K	﹤0.01%	70
2013 Q4	$15K	Hold	44,150	–	–	﹤0.01%	79
2013 Q3	$84K	Hold	44,150	–	–	﹤0.01%	74
2013 Q2	$84K	Buy	+44,150	New	+$77.6K	﹤0.01%	95

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BCM

Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Osterweis Capital Management's GCVRZ Position: Q3 2017 in Review

Osterweis Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2017, closing a stake of 50,000 shares — an estimated $19K sold.

Osterweis Capital Management first reported a position in GCVRZ in Q2 2013 and held it in 17 quarters. The position peaked at $110K in Q4 2014. 111 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2017.

Osterweis Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q3 2017 after selling out during the quarter.
Osterweis Capital Management sold 50,000 Sanofi Contingent Value Rights shares in Q3 2017, an estimated $19K.
Osterweis Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 17 quarters.
Osterweis Capital Management's Sanofi Contingent Value Rights position peaked at $110K in Q4 2014.
111 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2017.

Based on Osterweis Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.